Cargando…

Tumor Mutational Burden and PD-L1 Expression in Non-Small-Cell Lung Cancer (NSCLC) in Southwestern China

PURPOSE: To explore the impact between the tumor mutational burden (TMB) and programmed death ligand-1 (PD-L1) expression on NSCLC in the Yunnan region of southwestern China. PATIENTS AND METHODS: Seventy-one NSCLC specimens that were pathologically confirmed were collected at first. The TMB and dri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Yuhui, Li, Quan, Du, Yaxi, Chen, Wanlin, Zhao, Guangqiang, Liu, Xing, Ye, Lianhua, Li, Hongsheng, Wang, Xiaoxiong, Liu, Junxi, Shen, Zhenghai, Ma, Luyao, Zhou, Yongchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292484/ https://www.ncbi.nlm.nih.gov/pubmed/32606739 http://dx.doi.org/10.2147/OTT.S255947

Ejemplares similares

Oncogenic Genetic Alterations in Non-Small-Cell Lung Cancer (NSCLC) in Southwestern China
por: Ma, Yuhui, et al.
Publicado: (2020)

Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
por: Ma, Yuhui, et al.
Publicado: (2021)

Mutational characteristics of Chinese Han and ethnic minorities in southwestern China: a propensity score matched analysis
por: Zhou, Yongchun, et al.
Publicado: (2022)

Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
por: Zhou, Yongchun, et al.
Publicado: (2017)

MicroRNA‐195 suppresses the progression of lung adenocarcinoma by directly targeting apelin
por: Zhou, Yongchun, et al.
Publicado: (2019)

lncRNA DLEU2 modulates cell proliferation and invasion of non-small cell lung cancer by regulating miR-30c-5p/SOX9 axis
por: Zhou, Yongchun, et al.
Publicado: (2019)

Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
por: Zhou, Yongchun, et al.
Publicado: (2018)

Survival analysis of patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment of Yunnan in southwestern China: a real-world study
por: Lin, Yanping, et al.
Publicado: (2023)

Unique profile on the progress free survival and overall survival in patients with advanced non-small cell lung cancer in the Qujing area, Southwest China
por: Ma, Yuhui, et al.
Publicado: (2023)

Linc00996 is a favorable prognostic factor in LUAD: Results from bioinformatics analysis and experimental validation
por: Shen, Zhenghai, et al.
Publicado: (2022)

Predictive value of tumor mutational burden for PD-1/PD-L1 inhibitors in NSCLC: A meta-analysis
por: Li, Wenjie, et al.
Publicado: (2023)

Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients
por: Cai, Jingjing, et al.
Publicado: (2021)

miR-107 inhibited malignant biological behavior of non-small cell lung cancer cells by regulating the STK33/ERK signaling pathway in vivo and vitro
por: Wei, Xueqiang, et al.
Publicado: (2020)

Evaluation of surgical outcomes and prognostic factors of second primary lung cancer based on a systematic review and meta-analysis
por: Zhao, Jie, et al.
Publicado: (2023)

MTA1-TJP1 interaction and its involvement in non-small cell lung cancer metastasis
por: Wang, Wei, et al.
Publicado: (2022)

Unique Profile of Driver Gene Mutations in Patients With Non-Small-Cell Lung Cancer in Qujing City, Yunnan Province, Southwest China
por: Zhou, Yongchun, et al.
Publicado: (2021)

WSB2 as a target of Hedgehog signaling promoted the malignant biological behavior of Xuanwei lung cancer through regulating Wnt/β-catenin signaling
por: Wei, Xueqiang, et al.
Publicado: (2020)

Tree shrew as a new animal model for the study of lung cancer
por: YE, LIANHUA, et al.
Publicado: (2016)

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
por: Niu, Mengke, et al.
Publicado: (2021)

Mechanistic study on the inhibition of Staphylococcus epidermidis biofilm by agrC-specific binding polypeptide
por: Xiang, Bingquan, et al.
Publicado: (2020)

Deciphering Microenvironment of NSCLC based on CD8+ TIL Density and PD-1/PD-L1 Expression
por: Lin, Ziying, et al.
Publicado: (2019)

Safety and Efficacy of Anti-PD-1/PD-L1 Inhibitors Compared With Docetaxel for NSCLC: A Systematic Review and Meta-Analysis
por: Ma, Long, et al.
Publicado: (2021)

Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
por: Zhang, Jie, et al.
Publicado: (2015)

Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT Images
por: Wang, Chengdi, et al.
Publicado: (2022)

Effect of prior therapy on tumor mutational burden in NSCLC
por: Jonna, Sushma, et al.
Publicado: (2021)

Association between response to anti-PD-1 treatment and blood soluble PD-L1 and IL-8 changes in patients with NSCLC
por: Yi, Ling, et al.
Publicado: (2023)

Case Report: An “Immune-Cold” EGFR Mutant NSCLC With Strong PD-L1 Expression Shows Resistance to Chemo-Immunotherapy
por: Zhao, Qian, et al.
Publicado: (2022)

Molecular Mechanism and Health Role of Functional Ingredients in Blueberry for Chronic Disease in Human Beings
por: Ma, Luyao, et al.
Publicado: (2018)

The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers
por: Yang, Yanlong, et al.
Publicado: (2017)

Ratiometric electrochemical OR gate assay for NSCLC-derived exosomes
por: Meng, Fanyu, et al.
Publicado: (2023)

Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
por: Li, Chuling, et al.
Publicado: (2019)

Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC
por: Jiang, Li, et al.
Publicado: (2019)

Outcome differences between PD-1/PD-L1 inhibitors-based monotherapy and combination treatments in NSCLC with brain metastases
por: Wang, Haowei, et al.
Publicado: (2023)

Wolbachia infection in field-collected Aedes aegypti in Yunnan Province, southwestern China
por: Zhang, HengDuan, et al.
Publicado: (2022)

YAP regulates PD-L1 expression in human NSCLC cells
por: Miao, Jinbai, et al.
Publicado: (2017)

Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
por: Bie, Fenglong, et al.
Publicado: (2022)

A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy
por: Wang, Yuanyuan, et al.
Publicado: (2021)

Evaluation of the roles and regulatory mechanisms of PD-1 target molecules in NSCLC progression
por: Zhang, Yun-Qiang, et al.
Publicado: (2021)

What does radiomics do in PD‐L1 blockade therapy of NSCLC patients?
por: Cui, Ruichen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_82grpkusu4sa2916csnd18inj5